Omega Fund Management, LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Omega Fund Management, LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q2 2022$1,923,000
+24.8%
51,5350.0%0.61%
+94.9%
Q1 2022$1,541,000
-12.7%
51,5350.0%0.32%
+26.0%
Q4 2021$1,765,000
-7.6%
51,5350.0%0.25%
+16.8%
Q3 2021$1,910,000
-5.1%
51,5350.0%0.21%
-6.1%
Q2 2021$2,012,000
-8.3%
51,5350.0%0.23%
+9.6%
Q1 2021$2,194,00051,5350.21%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders